Cargando…

Global Trends in CD4 Cell Count at the Start of Antiretroviral Therapy: Collaborative Study of Treatment Programs

BACKGROUND: Early initiation of combination antiretroviral therapy (cART), at higher CD4 cell counts, prevents disease progression and reduces sexual transmission of human immunodeficiency virus (HIV). We describe the temporal trends in CD4 cell counts at the start of cART in adults from low-income,...

Descripción completa

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2018
Materias:	Articles and Commentaries
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5848308/ https://www.ncbi.nlm.nih.gov/pubmed/29373672 http://dx.doi.org/10.1093/cid/cix915

Ejemplares similares

CD4:CD8 Ratio and CD8 Count as Prognostic Markers for Mortality in Human Immunodeficiency Virus–Infected Patients on Antiretroviral Therapy: The Antiretroviral Therapy Cohort Collaboration (ART-CC)
por: Trickey, Adam, et al.
Publicado: (2017)

Challenges in initiating antiretroviral therapy for all HIV-infected people regardless of CD4 cell count
por: Bigna, Jean Joel R., et al.
Publicado: (2016)

Laboratory adverse events and discontinuation of therapy according to CD4(+) cell count at the start of antiretroviral therapy
por: Jose, Sophie, et al.
Publicado: (2014)

Mortality According to CD4 Count at Start of Combination Antiretroviral Therapy Among HIV-infected Patients Followed for up to 15 Years After Start of Treatment: Collaborative Cohort Study
por: May, Margaret T., et al.
Publicado: (2016)

Early Antiretroviral Therapy at High CD4 Counts Does Not Improve Arterial Elasticity: A Substudy of the Strategic Timing of AntiRetroviral Treatment (START) Trial
por: Baker, Jason V., et al.
Publicado: (2016)

Prioritization of antiretroviral therapy in patients with high CD4 counts, and retention in care: lessons from the START and Temprano trials
por: Schechter, Mauro
Publicado: (2018)

Immediate Antiretroviral Therapy Decreases Mortality Among Patients With High CD4 Counts in China: A Nationwide, Retrospective Cohort Study
por: Zhao, Yan, et al.
Publicado: (2018)

CD4+ T-Cell Count at Antiretroviral Therapy Initiation in the “Treat-All” Era in Rural South Africa: An Interrupted Time Series Analysis
por: Yapa, H Manisha, et al.
Publicado: (2021)

Development and Validation of Decision Rules to Guide Frequency of Monitoring CD4 Cell Count in HIV-1 Infection before Starting Antiretroviral Therapy
por: Buclin, Thierry, et al.
Publicado: (2011)

Safety and Efficacy of Starting Antiretroviral Therapy in the First Week of Life
por: Maswabi, Kenneth, et al.
Publicado: (2020)

Long-Term CD4+ Cell Count in Response to Combination Antiretroviral Therapy
por: Luz, Paula M., et al.
Publicado: (2014)

Renal dysfunction by baseline CD4 cell count in a cohort of adults starting antiretroviral treatment regardless of CD4 count in the HIV Prevention Trials Network 071 [HPTN 071; Population Effect of Antiretroviral Therapy to Reduce HIV Transmission (PopART)] study in South Africa
por: Bock, P, et al.
Publicado: (2019)

High Current CD4+ T Cell Count Predicts Suboptimal Adherence to Antiretroviral Therapy
por: Pasternak, Alexander O., et al.
Publicado: (2015)

Trends of CD4 cell count levels at the initiation of antiretroviral therapy over time and factors associated with late initiation of antiretroviral therapy among Asian HIV-positive patients
por: Kiertiburanakul, Sasisopin, et al.
Publicado: (2014)

A complex system of chemokines may hold the key to optimal CD4+ T-cell recovery after antiretroviral therapy
por: Sun, Yan V., et al.
Publicado: (2020)

CD4 lymphocyte count: A Barometer for HIV/AIDS Management
por: Sulaiman, Nassar
Publicado: (2012)

Modelling trends of CD4 counts for patients on antiretroviral therapy (ART): a comprehensive health care clinic in Nairobi, Kenya
por: Mugo, Caroline W., et al.
Publicado: (2022)

Absolute Lymphocyte Count Is Not a Suitable Alternative to CD4 Count for Determining Initiation of Antiretroviral Therapy in Fiji
por: Balak, Dashika A., et al.
Publicado: (2014)

Comparing Absolute Lymphocyte Count to Total Lymphocyte Count, as a CD4 T Cell Surrogate, to Initiate Antiretroviral Therapy
por: Sreenivasan, Srirangaraj, et al.
Publicado: (2011)

Is total lymphocyte count a predictor for CD4 cell count in initiation antiretroviral therapy in HIV-infected patients?
por: Abdollahi, Alireza, et al.
Publicado: (2014)

Long terms trends in CD4(+) cell counts, CD8(+) cell counts, and the CD4(+) : CD8(+) ratio
por: Hughes, Rachael A., et al.
Publicado: (2018)

CD4+:CD8+ T Cell Ratio Normalization and the Development of AIDS Events in People with HIV Starting Antiretroviral Therapy
por: Okhai, Hajra, et al.
Publicado: (2020)

Home-based versus clinic-based care for patients starting antiretroviral therapy with low CD4(+) cell counts: findings from a cluster-randomized trial
por: Woodd, Susannah L., et al.
Publicado: (2014)

When to Start Antiretroviral Therapy
por: Jain, Vivek, et al.
Publicado: (2010)

Antiretroviral treatment regardless of CD4 count: the universal answer to a contextual question
por: Eholié, Serge P., et al.
Publicado: (2016)

Application of The Change Point Analysis to The Long-Term Restoration of CD4 Count Among Well-Controlled HIV-1 Infected Patients Who Started Antiretroviral Therapy
por: Yoshikazu, Mutoh, et al.
Publicado: (2017)

Empiric Deworming and CD4 Count Recovery in HIV-Infected Ugandans Initiating Antiretroviral Therapy
por: Lankowski, Alexander J., et al.
Publicado: (2014)

Global health collaborative research: beyond mandatory collaboration to mandatory authorship
por: Nyangulu, Wongani John
Publicado: (2023)

CD4(+) cell count recovery following initiation of HIV antiretroviral therapy in older childhood and adolescence
por: Simms, Victoria, et al.
Publicado: (2018)

CD4+ cell count recovery after initiation of antiretroviral therapy in HIV-infected Ethiopian adults
por: Fiseha, Temesgen, et al.
Publicado: (2022)

Trend of CD4+ Cell Counts at Diagnosis and Initiation of Highly Active Antiretroviral Therapy (HAART): Korea HIV/AIDS Cohort Study, 1992-2015
por: Kim, Min Jung, et al.
Publicado: (2017)

Launching an Interactive Cancer Projects Map: A Collaborative Approach to Global Cancer Research and Program Development
por: Trimble, Edward L., et al.
Publicado: (2015)

Absolute lymphocyte count as a marker for CD4 lymphocyte count: criterion for initiating antiretroviral therapy in HIV-infected Nigerians
por: Erhabor, Osaro, et al.
Publicado: (2009)

Effect of Traditional Chinese Medicine Therapy on the Trend in CD4(+) T-Cell Counts among Patients with HIV/AIDS Treated with Antiretroviral Therapy: A Retrospective Cohort Study
por: Wang, Dongli, et al.
Publicado: (2021)

Global trends in antiretroviral resistance in treatment-naive individuals with HIV after rollout of antiretroviral treatment in resource-limited settings: a global collaborative study and meta-regression analysis
por: Gupta, Ravindra K, et al.
Publicado: (2012)

Beyond the Absence of CD4 T-Cell Count: A Novel Genetic CD4 T-Cell Deficiency Disorder With a Contingency Plan
por: Routy, Jean-Pierre, et al.
Publicado: (2021)

CD4 Counts at Entry to HIV Care in Mexico for Patients under the “Universal Antiretroviral Treatment Program for the Uninsured Population,” 2007–2014
por: Hernández-Romieu, Alfonso C., et al.
Publicado: (2016)

Life Expectancies of South African Adults Starting Antiretroviral Treatment: Collaborative Analysis of Cohort Studies
por: Johnson, Leigh F., et al.
Publicado: (2013)

Cardiovascular Disease and Antiretroviral Therapy
por: Jarwani, Bhavesh
Publicado: (2019)

Antiretroviral therapy suppressed participants with low CD4(+) T-cell counts segregate according to opposite immunological phenotypes
por: Pérez-Santiago, Josué, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_kul9mju6d5gcna54q1tq6k0usl